Detalhe da pesquisa
1.
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures.
Lancet Oncol
; 24(6): e270-e283, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37269858
2.
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium.
Lancet Oncol
; 21(2): e83-e96, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32007209
3.
Duration of treatment among patients prescribed afatinib or erlotinib as first-line therapy for EGFR mutation-positive non-small-cell lung cancer in the USA.
Future Oncol
; 15(13): 1493-1504, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30888202
4.
Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review.
Lancet Oncol
; 19(9): e459-e469, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30191850
5.
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials.
Clin Trials
; 15(6): 624-630, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30141714
6.
Nintedanib plus docetaxel as second-line therapy in patients with non-small-cell lung cancer of adenocarcinoma histology: a network meta-analysis vs new therapeutic options.
Future Oncol
; 13(13): 1159-1171, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28326832
7.
Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards.
Lancet Oncol
; 17(11): e510-e514, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27769798
8.
Nintedanib plus docetaxel as second-line therapy in patients with non-small-cell lung cancer: a network meta-analysis.
Future Oncol
; 11(3): 409-20, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25478720
9.
Patient-reported outcome labeling claims and measurement approach for metastatic castration-resistant prostate cancer treatments in the United States and European Union.
Health Qual Life Outcomes
; 12: 104, 2014 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-24989428
10.
A Mixed-Methods Study to Better Measure Patient-Reported Pain and Fatigue in Soft Tissue Sarcoma.
Oncol Ther
; 11(1): 129-143, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36633810
11.
Development of a disease conceptual model of patient experience with metastatic colorectal cancer: identification of the most salient symptoms and impacts.
J Cancer Surviv
; 2022 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36515691
12.
Measuring the Patient Experience in Rare Disorders: Benefit of Pragmatic Mixed-Methods Research in NUT Carcinoma.
Oncol Ther
; 10(1): 263-277, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35301699
13.
Understanding the Patient Experience in NUT Carcinoma: Qualitative Interviews with Patients and Caregivers to Develop a Conceptual Framework.
Oncol Ther
; 9(2): 591-605, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34357582
14.
SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials.
BMJ Open
; 11(6): e045105, 2021 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34193486
15.
Network meta-analyses for EGFR mutation-positive non-small-cell lung cancer: systematic review and overview of methods and shortcomings.
J Comp Eff Res
; 9(17): 1179-1194, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33112179
16.
Healthcare resource utilization and costs associated with patients prescribed afatinib or erlotinib as first-line therapy for EGFR mutation-positive NSCLC in the United States.
J Med Econ
; 23(1): 48-53, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31314630
17.
Budget impact of sequential treatment with first-line afatinib versus first-line osimertinib in non-small-cell lung cancer patients with common EGFR mutations.
Eur J Health Econ
; 21(6): 931-943, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32328874
18.
What is an estimand & how does it relate to quantifying the effect of treatment on patient-reported quality of life outcomes in clinical trials?
J Patient Rep Outcomes
; 4(1): 68, 2020 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32833083
19.
Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 Analyses.
Clin Colorectal Cancer
; 18(4): 269-279.e5, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31628043
20.
An economic evaluation of cetuximab combined with radiotherapy for patients with locally advanced head and neck cancer in Belgium, France, Italy, Switzerland, and the United Kingdom.
Value Health
; 11(5): 791-9, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18194407